Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
Gilead Sciences (NASDAQ: GILD) Delayed: 125.73 +0.86 (0.69%)
Previous Close $124.87    52 Week High $108.63 
Open $126.63    52 Week Low $71.39 
Day High $126.63    P/E 69.46 
Day Low $124.44    EPS $1.81 
Volume 1,589,989